- BIO.NRW
- Aktuelles
- Standort
- Finanzierung
- Kooperationen
- Veranstaltungen
- Videowettbewerb
- BIO.NRW.academy
- Arbeitsplattform BIO.NRW.red
- Expertenrunde BIO.NRW.red
- BIO-Europe
- PerMediCon
- Student Convention
- Business Angel Kongress
- BIO Chicago
- Firmendatenbank
- Wissenschaftsdatenbank
- Jobbörse
- Downloadcenter
- Presse
- Intern
BIO.NRW-Newsticker
Aktuelles aus Wirtschaft und Wissenschaft
Aktuelle Unternehmensmitteilungen aus NRW
2012-12-20
Cevec Licenses CAP Technology to Yuhan Corporation (ROK)
Cevec Pharmaceuticals GmbH. (12/20/12). "Press Release: Cevec Pharmaceuticals Signs License Agreement with Yuhan Corporation". Cologne.
CEVEC Pharmaceuticals ("CEVEC"), the developer of a novel human expression system derived from amniocytes, and Yuhan Corporation ("Yuhan"), a leading manufacturer of pharmaceutical products based in Seoul, South Korea announced today the signing of a... [more]
2012-12-13
Cube Biotech’s Series A Financing Led by Creathor Venture
Cube Biotech GmbH. (12/13/12). "Press Release: Startup Cube Biotech Attracts Financing from Creathor Venture".
Cube Biotech receives a series-A financing led by Creathor Venture and joined by local business angels. The recently founded company will use the proceeds to enlarge its product portfolio in the field of production and crystallization of membrane pro... [more]
2012-12-11
Anagnostics Uses Scienion’s sciFlexarrayer for Sepsis Test
Scienion AG. (12/11/12). "Press Release: Scienion’s sciFlexarrayer Used for the Production of Anagnostics’ Integrated Sepsis Testing Products". Dortmund & St. Valentin.
SCIENION AG and Anagnostics Bioanalysis GmbH today announced that Anagnostics is using Scienion's sciFLEXARRAYER for the production of Anagnostics new product line focusing on integrated sepsis testing, based on DNA and protein based multiplex assays... [more]
2012-12-06
Constantin Fest to Head Investor Relations at Merck KGaA
Merck KGaA. (12/6/12). "Press Release: Constantin Fest to Head Merck Investor Relations". Darmstadt.
Merck announced today that Constantin Fest will head its Investor Relations department as of January 1, 2013. He will succeed Joshua Young, who - after spending nearly eight years at Merck and Millipore - has decided to transition back to the USA, wh... [more]
2012-11-30
HZI and Robert Koch Institute Sign Collaboration Agreement
Helmholtz-Zentrum für Infektionsforschung (HZI. (11/30/12). "Press Release: Concentrated Competencies in the Fight against Infectious Diseases. HZI and the Robert Koch Institute Sign Collaboration Agreement".
The Helmholtz Centre for Infection Research and the Robert Koch Institute will bundle their expertise in the future.
Two leaders in the field of infection research are planning on bundling their expertise in the future. Scientists at the Helmhol... [more]
